Enliven Therapeutics (ELVN) Fair Value & DCF

ELVN$48.80+0.49 +1.01%
BiotechnologyGrowth Stock
Compare
Market cap$3.59BEnterprise value$3.62BRevenue (TTM)$0Market position—

Score

68
Bullish
Value
58
Quality
47
Growth
100

Enliven Therapeutics, Inc. (ELVN) trades at $48.80 on $3.59B of equity value, with a trailing P/E of -30.47. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Enliven Therapeutics (ELVN) Fair Value & DCF

ELVN price $48.80 +0.49 +1.01%

Ticker
ELVN
Price
$48.80
Change
+0.49 +1.01%
Market cap
$3.59B
Dividend yield
0.00%
Beta
0.24
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
58
Quality
47
Growth
100

Stocklytics score rationale: value 58, quality 47, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener